Hemophilia B gene therapy reduced bleeding and supported lasting clotting levels, even in some patients with antibodies, new ...

My 20-year-old son, Caeleb, is a college sophomore. He rides a bike on campus and loves the freedom of biking everywhere. He ...

With multiple von Willebrand disease therapies approaching clinical trials, columnist Jennifer Lynne is excited about the future of treatment.

Guest columnist Sazia Suchita says she finds comfort in her faith after her mother's passing and her sons' hemophilia diagnoses.

Columnist G Shellye Horowitz reflects on the many clues around her — the calm in the storm — that brought reassurance during a recent surgery.